Drug application
DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)
Drugs@FDA ANDA 064097 · HIKMA
Key facts
| Drug name | DOXORUBICIN HYDROCHLORIDE |
|---|---|
| Active ingredients | DOXORUBICIN HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 064097 |
| Company | HIKMA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 200MG/100ML |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Sep 13, 1994 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: